OS Therapies Inc (OSTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of OSTX. The 7-day demo opens the 1M and 3M ranges and puts OSTX on your watchlist.
Start 7-day demoLatest OSTX insider trades
About OS Therapies Inc (OSTX)
OS Therapies Inc files with the SEC under CIK 0001795091 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
OSTX Form 4 activity by transaction type, last 90 days
No Form 4 activity for OSTX in the last 90 days.
OSTX insider transactions (Form 4)
1616 Form 4 filings on record, the earliest from Dec 19, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Avril Suzette McKean-Dieser - Director | Grant or award | Stock options (right to buy) | 50,000 | $0.00 | - | |
| Theodore F. Search - Director | Grant or award | Stock options (right to buy) | 50,000 | $0.00 | - | |
| John Ciccio - Director | Grant or award | Stock options (right to buy) | 50,000 | $0.00 | - | |
| Christopher P. Acevedo - Officer | Grant or award | Stock options (right to buy) | 100,000 | $0.00 | - | |
| Robert Petit - Officer | Grant or award | Stock options (right to buy) | 100,000 | $0.00 | - | |
| Olivier Roger Jarry - Director | Grant or award | Stock options (right to buy) | 50,000 | $0.00 | - | |
| Karim Galzahr - Director | Grant or award | Stock options (right to buy) | 50,000 | $0.00 | - | |
| Paul A. Romness - Officer | Grant or award | Stock options (right to buy) | 1,000,000 | $0.00 | - | |
| Theodore F. Search - Director | Grant or award | Stock options (right to buy) | 140,000 | $0.00 | - | |
| Robert Petit - Officer | Grant or award | Stock options (right to buy) | 500,000 | $0.00 | - | |
| Paul A. Romness - Officer | Grant or award | Stock options (right to buy) | 1,950,000 | $0.00 | - | |
| Olivier Roger Jarry - Director | Grant or award | Stock options (right to buy) | 140,000 | $0.00 | - | |
| Karim Galzahr - Director | Grant or award | Stock options (right to buy) | 140,000 | $0.00 | - | |
| John Ciccio - Director | Grant or award | Stock options (right to buy) | 140,000 | $0.00 | - | |
| Christopher P. Acevedo - Officer | Grant or award | Stock options (right to buy) | 200,000 | $0.00 | - | |
| Avril Suzette McKean-Dieser - Director | Grant or award | Stock options (right to buy) | 140,000 | $0.00 | - |
OSTX insider trading FAQ
What is the latest insider trade for OSTX?
OS Therapies Inc (OSTX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-02-13. The full record for OSTX runs to 16 Form 4 filings, the earliest from 2025-12-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying OSTX stock?
No insider purchases of OSTX were filed in the last 90 days.
How many insiders are selling OSTX stock?
No insider sales of OSTX were filed in the last 90 days.
Where can I see OSTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects OSTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Avril Suzette McKean-Dieser view on EDGAR
- - Theodore F. Search view on EDGAR
- - John Ciccio view on EDGAR
- - Christopher P. Acevedo view on EDGAR
- - Robert Petit view on EDGAR
- - Olivier Roger Jarry view on EDGAR
- - Karim Galzahr view on EDGAR
- - Paul A. Romness view on EDGAR
- - Theodore F. Search view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where OSTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow OSTX with a 7-day demo
- OSTX on your watchlist
- Every OSTX Form 4 filing on record
- Up to 3 months of OSTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
